Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab induction in living donor renal transplantation
ISRCTN95769119Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Nov 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 4, open-label trial of rituximab in kidney failure (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Glomerular filtration rate at 12 months. Started Nov 2010; status: completed.
02
Drugs
rituximab
03
Conditions
kidney failure
Beyond the preview
Go deeper on ISRCTN95769119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN95769119.